

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.93055448 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.89795103 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.89795103 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.69255736 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.69255736 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.68637785 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.59037667 |
| 8 | negative T cell selection (GO:0043383) | 5.44521811 |
| 9 | negative thymic T cell selection (GO:0045060) | 5.42599869 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.34786238 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.24582369 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.15525541 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.12431011 |
| 14 | thymic T cell selection (GO:0045061) | 4.87688090 |
| 15 | positive T cell selection (GO:0043368) | 4.82530063 |
| 16 | response to interleukin-15 (GO:0070672) | 4.69001532 |
| 17 | T cell selection (GO:0045058) | 4.53547580 |
| 18 | tolerance induction (GO:0002507) | 4.49389161 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.42733984 |
| 20 | interferon-gamma production (GO:0032609) | 4.38587560 |
| 21 | T cell migration (GO:0072678) | 4.36982214 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.34551646 |
| 23 | detection of other organism (GO:0098543) | 4.31939154 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.28481093 |
| 25 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.22593499 |
| 26 | detection of bacterium (GO:0016045) | 4.16810852 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 4.16127131 |
| 28 | response to peptidoglycan (GO:0032494) | 4.10137906 |
| 29 | regulation of B cell differentiation (GO:0045577) | 4.01718636 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99762184 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.99437120 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.88853683 |
| 33 | cellular extravasation (GO:0045123) | 3.70158999 |
| 34 | * leukocyte aggregation (GO:0070486) | 3.66850075 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 3.65541557 |
| 36 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.64049966 |
| 37 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.63654150 |
| 38 | T cell receptor signaling pathway (GO:0050852) | 3.63642899 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.62610808 |
| 40 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.58380711 |
| 41 | positive regulation of tolerance induction (GO:0002645) | 3.57191078 |
| 42 | activated T cell proliferation (GO:0050798) | 3.57150194 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56387753 |
| 44 | T cell costimulation (GO:0031295) | 3.54525473 |
| 45 | lymphocyte costimulation (GO:0031294) | 3.47325929 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44299321 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.42747564 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.41595936 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.41595936 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.40983134 |
| 51 | detection of molecule of bacterial origin (GO:0032490) | 3.40501525 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.36997473 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.36716771 |
| 54 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.35206915 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33139746 |
| 56 | response to host immune response (GO:0052572) | 3.33139746 |
| 57 | microglial cell activation (GO:0001774) | 3.32836572 |
| 58 | granulocyte activation (GO:0036230) | 3.30314787 |
| 59 | positive regulation of interleukin-2 production (GO:0032743) | 3.29813214 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.27835799 |
| 61 | * leukocyte cell-cell adhesion (GO:0007159) | 3.25751819 |
| 62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.25094524 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.20790007 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.19695410 |
| 65 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18631029 |
| 66 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18631029 |
| 67 | modulation by symbiont of host immune response (GO:0052553) | 3.18631029 |
| 68 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18631029 |
| 69 | modulation by symbiont of host defense response (GO:0052031) | 3.18631029 |
| 70 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18631029 |
| 71 | macrophage activation (GO:0042116) | 3.18162184 |
| 72 | defense response to protozoan (GO:0042832) | 3.14973291 |
| 73 | response to host (GO:0075136) | 3.14100829 |
| 74 | response to host defenses (GO:0052200) | 3.14100829 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14100829 |
| 76 | positive regulation of isotype switching (GO:0045830) | 3.11374489 |
| 77 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.07919849 |
| 78 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07295191 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 3.06420383 |
| 80 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05839174 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05107175 |
| 82 | T cell homeostasis (GO:0043029) | 3.03442431 |
| 83 | lymphocyte homeostasis (GO:0002260) | 3.01840717 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01686599 |
| 85 | mast cell activation (GO:0045576) | 3.00613428 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00048281 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99820331 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.98641031 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98493934 |
| 90 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.97197289 |
| 91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.97011798 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96763111 |
| 93 | response to protozoan (GO:0001562) | 2.96556439 |
| 94 | neutrophil mediated immunity (GO:0002446) | 2.95933548 |
| 95 | regulation of response to interferon-gamma (GO:0060330) | 2.94789028 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 2.94449386 |
| 97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94224731 |
| 98 | negative regulation of phagocytosis (GO:0050765) | 2.94151967 |
| 99 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.91157712 |
| 100 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.90814447 |
| 101 | leukocyte degranulation (GO:0043299) | 2.90349558 |
| 102 | negative regulation of innate immune response (GO:0045824) | 2.90121388 |
| 103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.89741673 |
| 104 | regulation of mast cell activation (GO:0033003) | 2.88855423 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88782784 |
| 106 | natural killer cell differentiation (GO:0001779) | 2.88582946 |
| 107 | B cell homeostasis (GO:0001782) | 2.87554812 |
| 108 | response to muramyl dipeptide (GO:0032495) | 2.87529007 |
| 109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86656680 |
| 110 | positive regulation of histone deacetylation (GO:0031065) | 2.86640036 |
| 111 | T cell proliferation (GO:0042098) | 2.86149937 |
| 112 | natural killer cell activation (GO:0030101) | 2.85652537 |
| 113 | B cell mediated immunity (GO:0019724) | 2.85156944 |
| 114 | mature B cell differentiation (GO:0002335) | 2.84295748 |
| 115 | myeloid dendritic cell activation (GO:0001773) | 2.83956176 |
| 116 | negative regulation of interleukin-6 production (GO:0032715) | 2.83730325 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.82494313 |
| 118 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79518020 |
| 119 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79518020 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78816894 |
| 121 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76585626 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 2.75247459 |
| 123 | hepatocyte apoptotic process (GO:0097284) | 2.71040819 |
| 124 | regulation of isotype switching (GO:0045191) | 2.69346099 |
| 125 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69074817 |
| 126 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68878219 |
| 127 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68228729 |
| 128 | positive regulation of humoral immune response (GO:0002922) | 2.67483082 |
| 129 | germinal center formation (GO:0002467) | 2.65426065 |
| 130 | heterotypic cell-cell adhesion (GO:0034113) | 2.65346295 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63348639 |
| 132 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.62921623 |
| 133 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.62836792 |
| 134 | positive regulation of B cell mediated immunity (GO:0002714) | 2.62836792 |
| 135 | response to type I interferon (GO:0034340) | 2.62308897 |
| 136 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.61609629 |
| 137 | respiratory burst (GO:0045730) | 2.61010824 |
| 138 | regulation of interleukin-2 production (GO:0032663) | 2.60607919 |
| 139 | B cell proliferation (GO:0042100) | 2.59995142 |
| 140 | regulation of B cell proliferation (GO:0030888) | 2.59642395 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.59072656 |
| 142 | neutrophil activation (GO:0042119) | 2.58429272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.68435875 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.91404862 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.15136418 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.78785478 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.68522970 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34026863 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33864777 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33666693 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28386713 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.14403855 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08720472 |
| 12 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.04325130 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.95722423 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.85306067 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.84802698 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79714864 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74314529 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.71086205 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68492664 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.61527734 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56348700 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.55571158 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51820191 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51350992 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49702736 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.47727252 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35437747 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.27217086 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.23437738 |
| 30 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18969447 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13311679 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11400849 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11248369 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08763528 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07943261 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.03758645 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03359044 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99953712 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84491617 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84151537 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82574685 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.80624875 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75249183 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73390771 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69309098 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68132258 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64267734 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56858374 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50077956 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49080538 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45628428 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44305720 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43811520 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.39177689 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38024358 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37177647 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35691519 |
| 58 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33299064 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28561192 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28082838 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22879786 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22155685 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21467434 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19022551 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17166297 |
| 66 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15230824 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12770349 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12312174 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11808645 |
| 70 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09941956 |
| 71 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09794178 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08965177 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07879790 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06923945 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06405159 |
| 76 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.05459226 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02719606 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00982325 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99788486 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98917595 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97145870 |
| 82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.96933628 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95625296 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95224609 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91443827 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91106143 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89385537 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88819240 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88058200 |
| 90 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87822031 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87406608 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87324070 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86370821 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85519594 |
| 95 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.83367590 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82915885 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82615247 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79686591 |
| 99 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79440111 |
| 100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78941065 |
| 101 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.77301690 |
| 102 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.76138948 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75089194 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74917752 |
| 105 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74869114 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74825280 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.73809278 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73638757 |
| 109 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73194419 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.70278066 |
| 111 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.70249802 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.66532751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.65824459 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.54073519 |
| 3 | MP0000685_abnormal_immune_system | 3.29988548 |
| 4 | MP0001800_abnormal_humoral_immune | 3.28683410 |
| 5 | MP0005671_abnormal_response_to | 3.26439653 |
| 6 | MP0005387_immune_system_phenotype | 3.15885819 |
| 7 | MP0001790_abnormal_immune_system | 3.15885819 |
| 8 | MP0003303_peritoneal_inflammation | 2.99606550 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.83609179 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.82260324 |
| 11 | MP0003436_decreased_susceptibility_to | 2.79035313 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.70235223 |
| 13 | MP0002723_abnormal_immune_serum | 2.69834608 |
| 14 | * MP0001819_abnormal_immune_cell | 2.66824631 |
| 15 | MP0002398_abnormal_bone_marrow | 2.57599342 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.56282091 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.45644412 |
| 18 | MP0005025_abnormal_response_to | 2.36201677 |
| 19 | MP0009785_altered_susceptibility_to | 2.33681709 |
| 20 | MP0001873_stomach_inflammation | 2.33651621 |
| 21 | MP0002419_abnormal_innate_immunity | 2.31478611 |
| 22 | MP0002405_respiratory_system_inflammati | 2.30371089 |
| 23 | MP0000716_abnormal_immune_system | 2.29609805 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.22668878 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.15054298 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.14476841 |
| 27 | MP0002722_abnormal_immune_system | 2.10356430 |
| 28 | MP0006082_CNS_inflammation | 2.07731822 |
| 29 | MP0004947_skin_inflammation | 2.06257927 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.03034446 |
| 31 | MP0000703_abnormal_thymus_morphology | 2.01724509 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.95970045 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.95465420 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.94049933 |
| 35 | MP0002429_abnormal_blood_cell | 1.91212815 |
| 36 | MP0009278_abnormal_bone_marrow | 1.86789754 |
| 37 | MP0004510_myositis | 1.84402444 |
| 38 | MP0002006_tumorigenesis | 1.80763368 |
| 39 | MP0003724_increased_susceptibility_to | 1.76181816 |
| 40 | MP0008260_abnormal_autophagy | 1.74981766 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.73598753 |
| 42 | MP0003866_abnormal_defecation | 1.70043718 |
| 43 | MP0005451_abnormal_body_composition | 1.69097402 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.63033357 |
| 45 | MP0001853_heart_inflammation | 1.62651461 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.59508150 |
| 47 | MP0002933_joint_inflammation | 1.53379336 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.49469537 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.49469537 |
| 50 | MP0004381_abnormal_hair_follicle | 1.45619584 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.43119202 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.35869108 |
| 53 | MP0000490_abnormal_crypts_of | 1.31648901 |
| 54 | MP0000858_altered_metastatic_potential | 1.29983477 |
| 55 | MP0003448_altered_tumor_morphology | 1.28560382 |
| 56 | MP0005310_abnormal_salivary_gland | 1.22677742 |
| 57 | MP0004883_abnormal_blood_vessel | 1.16352248 |
| 58 | MP0008469_abnormal_protein_level | 1.13297195 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.12438023 |
| 60 | MP0001851_eye_inflammation | 1.09235364 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.08511795 |
| 62 | MP0005023_abnormal_wound_healing | 1.06312019 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.02180574 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.01800149 |
| 65 | MP0005164_abnormal_response_to | 1.00636633 |
| 66 | MP0003045_fibrosis | 1.00288298 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 0.99324684 |
| 68 | MP0000569_abnormal_digit_pigmentation | 0.97668295 |
| 69 | MP0003075_altered_response_to | 0.95694319 |
| 70 | MP0010307_abnormal_tumor_latency | 0.95573401 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.95373990 |
| 72 | MP0003091_abnormal_cell_migration | 0.95233763 |
| 73 | MP0005058_abnormal_lysosome_morphology | 0.94499930 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 0.94413886 |
| 75 | MP0003690_abnormal_glial_cell | 0.93699447 |
| 76 | MP0003077_abnormal_cell_cycle | 0.92315835 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.92228842 |
| 78 | MP0000604_amyloidosis | 0.91718903 |
| 79 | MP0008057_abnormal_DNA_replication | 0.89805157 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.87263233 |
| 81 | MP0003828_pulmonary_edema | 0.86402657 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.85589591 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.80099695 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.76441082 |
| 85 | MP0003279_aneurysm | 0.75009044 |
| 86 | MP0004130_abnormal_muscle_cell | 0.74905018 |
| 87 | MP0008004_abnormal_stomach_pH | 0.74035886 |
| 88 | MP0000343_altered_response_to | 0.73164868 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.72516011 |
| 90 | MP0010094_abnormal_chromosome_stability | 0.72346637 |
| 91 | MP0009840_abnormal_foam_cell | 0.72336355 |
| 92 | MP0002009_preneoplasia | 0.70092966 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.69305865 |
| 94 | MP0002132_abnormal_respiratory_system | 0.69223434 |
| 95 | MP0009763_increased_sensitivity_to | 0.69170263 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67185840 |
| 97 | MP0001663_abnormal_digestive_system | 0.65783922 |
| 98 | MP0000249_abnormal_blood_vessel | 0.65609312 |
| 99 | MP0005166_decreased_susceptibility_to | 0.65207869 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.65048733 |
| 101 | MP0009764_decreased_sensitivity_to | 0.64977818 |
| 102 | MP0003111_abnormal_nucleus_morphology | 0.64586905 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 0.64542756 |
| 104 | MP0005670_abnormal_white_adipose | 0.64314899 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.64205009 |
| 106 | MP0008874_decreased_physiological_sensi | 0.64145257 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.63293327 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.58486239 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.58426927 |
| 110 | MP0003795_abnormal_bone_structure | 0.57741261 |
| 111 | MP0005390_skeleton_phenotype | 0.57347103 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.56613766 |
| 113 | MP0005621_abnormal_cell_physiology | 0.55709379 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.55521581 |
| 115 | MP0000313_abnormal_cell_death | 0.54750261 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.54474974 |
| 117 | MP0000609_abnormal_liver_physiology | 0.53049728 |
| 118 | MP0000733_abnormal_muscle_development | 0.52676406 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.52164648 |
| 120 | MP0000371_diluted_coat_color | 0.49494768 |
| 121 | MP0006054_spinal_hemorrhage | 0.48186021 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.44993522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.67329982 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.52917324 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.50682510 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.45434959 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.40676985 |
| 6 | Recurrent viral infections (HP:0004429) | 4.38612826 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.35488328 |
| 8 | IgM deficiency (HP:0002850) | 4.33731121 |
| 9 | Chronic otitis media (HP:0000389) | 3.99564262 |
| 10 | Nasal polyposis (HP:0100582) | 3.92895629 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84205788 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.82881292 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78770328 |
| 14 | Pustule (HP:0200039) | 3.78482883 |
| 15 | Myositis (HP:0100614) | 3.77969780 |
| 16 | Abnormality of T cells (HP:0002843) | 3.67239426 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.62264365 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.60141535 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59022533 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59022533 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.50585373 |
| 22 | Cellulitis (HP:0100658) | 3.47716787 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.46393645 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.45162403 |
| 25 | Stomatitis (HP:0010280) | 3.43534207 |
| 26 | Meningitis (HP:0001287) | 3.41589886 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.39737072 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.38622841 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.30212855 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.30125804 |
| 31 | Colitis (HP:0002583) | 3.29568632 |
| 32 | Lymphopenia (HP:0001888) | 3.18420637 |
| 33 | Increased IgM level (HP:0003496) | 3.11041582 |
| 34 | Recurrent skin infections (HP:0001581) | 3.09782591 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.07137676 |
| 36 | Vasculitis (HP:0002633) | 3.05927413 |
| 37 | Keratoconjunctivitis (HP:0001096) | 3.02214373 |
| 38 | Verrucae (HP:0200043) | 3.00323510 |
| 39 | Papilloma (HP:0012740) | 3.00323510 |
| 40 | Obstructive lung disease (HP:0006536) | 2.94094662 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94094662 |
| 42 | Urticaria (HP:0001025) | 2.93785420 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.87828543 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85915221 |
| 45 | Thyroiditis (HP:0100646) | 2.85791791 |
| 46 | Recurrent sinusitis (HP:0011108) | 2.84665660 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.81492342 |
| 48 | Optic neuritis (HP:0100653) | 2.80868488 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.80868488 |
| 50 | Orchitis (HP:0100796) | 2.77555470 |
| 51 | Eosinophilia (HP:0001880) | 2.76989864 |
| 52 | Leukocytosis (HP:0001974) | 2.75086499 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.74898626 |
| 54 | Increased IgE level (HP:0003212) | 2.65885828 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.64936153 |
| 56 | B lymphocytopenia (HP:0010976) | 2.64914317 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.64914317 |
| 58 | Chronic diarrhea (HP:0002028) | 2.63703428 |
| 59 | IgG deficiency (HP:0004315) | 2.62029462 |
| 60 | Gastrointestinal stroma tumor (HP:0100723) | 2.60946896 |
| 61 | Abnormality of eosinophils (HP:0001879) | 2.58592565 |
| 62 | Slow saccadic eye movements (HP:0000514) | 2.54348931 |
| 63 | Increased density of long bones (HP:0006392) | 2.49409968 |
| 64 | IgA deficiency (HP:0002720) | 2.48894632 |
| 65 | Bronchitis (HP:0012387) | 2.48669735 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.45380393 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44801143 |
| 68 | Hemoptysis (HP:0002105) | 2.44156993 |
| 69 | Granulocytopenia (HP:0001913) | 2.43713308 |
| 70 | Hypochromic anemia (HP:0001931) | 2.43222504 |
| 71 | Chronic sinusitis (HP:0011109) | 2.42136995 |
| 72 | Emphysema (HP:0002097) | 2.41592522 |
| 73 | Arterial thrombosis (HP:0004420) | 2.40703668 |
| 74 | Gingivitis (HP:0000230) | 2.40384065 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39384052 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39384052 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39384052 |
| 78 | Periodontitis (HP:0000704) | 2.38824593 |
| 79 | Encephalitis (HP:0002383) | 2.37977941 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.37798663 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.37509704 |
| 82 | Hematochezia (HP:0002573) | 2.36765969 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.35735534 |
| 84 | Anorexia (HP:0002039) | 2.34896613 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.34416547 |
| 86 | Peritonitis (HP:0002586) | 2.28504236 |
| 87 | Osteomyelitis (HP:0002754) | 2.27351304 |
| 88 | Episodic fever (HP:0001954) | 2.27020994 |
| 89 | Thrombocytosis (HP:0001894) | 2.22937069 |
| 90 | Chest pain (HP:0100749) | 2.22703385 |
| 91 | Cerebral aneurysm (HP:0004944) | 2.22616289 |
| 92 | Lymphoma (HP:0002665) | 2.21953330 |
| 93 | Epistaxis (HP:0000421) | 2.19941964 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.19517046 |
| 95 | Keratitis (HP:0000491) | 2.14336014 |
| 96 | Gangrene (HP:0100758) | 2.12531120 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 2.11175707 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.10185194 |
| 99 | Petechiae (HP:0000967) | 2.07796834 |
| 100 | Restrictive lung disease (HP:0002091) | 2.07603113 |
| 101 | Amyloidosis (HP:0011034) | 2.07184416 |
| 102 | Skin ulcer (HP:0200042) | 2.05548603 |
| 103 | Recurrent otitis media (HP:0000403) | 2.04370881 |
| 104 | Papilledema (HP:0001085) | 2.03888690 |
| 105 | Microcytic anemia (HP:0001935) | 2.03429414 |
| 106 | Basal cell carcinoma (HP:0002671) | 2.02380239 |
| 107 | Autoimmune hemolytic anemia (HP:0001890) | 2.01961431 |
| 108 | Viral hepatitis (HP:0006562) | 2.01919105 |
| 109 | Increased serum ferritin (HP:0003281) | 1.99501954 |
| 110 | Glomerulopathy (HP:0100820) | 1.98483048 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98343539 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 1.97967123 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.97821013 |
| 114 | Loss of speech (HP:0002371) | 1.96976888 |
| 115 | Dysostosis multiplex (HP:0000943) | 1.96218476 |
| 116 | Joint swelling (HP:0001386) | 1.93848829 |
| 117 | Sepsis (HP:0100806) | 1.93182358 |
| 118 | Cheilitis (HP:0100825) | 1.92992056 |
| 119 | Gingival bleeding (HP:0000225) | 1.90147237 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.90033721 |
| 121 | Purpura (HP:0000979) | 1.88096994 |
| 122 | Retinal atrophy (HP:0001105) | 1.87222906 |
| 123 | Fatigue (HP:0012378) | 1.86463408 |
| 124 | Pulmonary embolism (HP:0002204) | 1.86279578 |
| 125 | Aortic aneurysm (HP:0004942) | 1.85495743 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.84776283 |
| 127 | Abnormal platelet function (HP:0011869) | 1.84776283 |
| 128 | Acute hepatic failure (HP:0006554) | 1.84624622 |
| 129 | Recurrent pneumonia (HP:0006532) | 1.84599213 |
| 130 | Increased mean platelet volume (HP:0011877) | 1.81791680 |
| 131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81298541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.77648544 |
| 2 | TXK | 3.79616251 |
| 3 | PRPF4B | 2.96490273 |
| 4 | TYK2 | 2.68751116 |
| 5 | JAK3 | 2.60279134 |
| 6 | GRK6 | 2.49921618 |
| 7 | ZAP70 | 2.46007771 |
| 8 | MAP3K10 | 2.43186865 |
| 9 | ITK | 2.41593583 |
| 10 | EEF2K | 2.24775420 |
| 11 | CDK12 | 2.19082986 |
| 12 | JAK1 | 1.98262824 |
| 13 | * STK10 | 1.97643487 |
| 14 | MAP3K14 | 1.90516277 |
| 15 | IKBKE | 1.88548451 |
| 16 | BLK | 1.87587819 |
| 17 | FGFR4 | 1.83203561 |
| 18 | BTK | 1.81876361 |
| 19 | CSK | 1.76372450 |
| 20 | TGFBR2 | 1.74558784 |
| 21 | TBK1 | 1.65180604 |
| 22 | CSF1R | 1.63523969 |
| 23 | LCK | 1.62817364 |
| 24 | HCK | 1.60132342 |
| 25 | MAP3K3 | 1.58951035 |
| 26 | PKN2 | 1.55921259 |
| 27 | IRAK4 | 1.54527246 |
| 28 | SYK | 1.54527124 |
| 29 | LRRK2 | 1.53127185 |
| 30 | TEC | 1.47343557 |
| 31 | FGFR3 | 1.46776182 |
| 32 | KIT | 1.45759645 |
| 33 | SIK2 | 1.45459507 |
| 34 | TRIB3 | 1.43257978 |
| 35 | NLK | 1.42556929 |
| 36 | MAP3K13 | 1.39220088 |
| 37 | MAP3K11 | 1.38859863 |
| 38 | ERN1 | 1.37927844 |
| 39 | EPHB1 | 1.32147734 |
| 40 | CLK1 | 1.27293022 |
| 41 | MAP2K3 | 1.26903150 |
| 42 | TTN | 1.22252151 |
| 43 | IKBKB | 1.21103466 |
| 44 | FES | 1.18150106 |
| 45 | RIPK4 | 1.16794927 |
| 46 | MAP3K1 | 1.13227601 |
| 47 | TAOK2 | 1.12208851 |
| 48 | RPS6KA4 | 1.11819042 |
| 49 | IRAK3 | 1.05545271 |
| 50 | MST4 | 1.02306193 |
| 51 | PRKCH | 1.02297438 |
| 52 | BMPR2 | 0.93689328 |
| 53 | CDK4 | 0.92459870 |
| 54 | MATK | 0.92400170 |
| 55 | CHUK | 0.90652028 |
| 56 | NEK2 | 0.90643897 |
| 57 | LYN | 0.90550392 |
| 58 | PTK2B | 0.89835106 |
| 59 | PRKCQ | 0.87966994 |
| 60 | JAK2 | 0.86665486 |
| 61 | YES1 | 0.85033854 |
| 62 | CDC42BPA | 0.82817300 |
| 63 | PTK6 | 0.82287786 |
| 64 | STK4 | 0.81893331 |
| 65 | IRAK1 | 0.80643075 |
| 66 | BRD4 | 0.80144428 |
| 67 | KSR2 | 0.79714817 |
| 68 | CAMK1D | 0.78348478 |
| 69 | SMG1 | 0.75776959 |
| 70 | * PIM1 | 0.75404085 |
| 71 | TAOK3 | 0.74757075 |
| 72 | CAMKK2 | 0.69543322 |
| 73 | TRPM7 | 0.67674758 |
| 74 | PDPK1 | 0.67081901 |
| 75 | CDK9 | 0.66544018 |
| 76 | TNK2 | 0.66275679 |
| 77 | GRK7 | 0.66043515 |
| 78 | MELK | 0.65563346 |
| 79 | ALK | 0.65498910 |
| 80 | SIK3 | 0.65440685 |
| 81 | CDK6 | 0.64263787 |
| 82 | KDR | 0.64164490 |
| 83 | MAP3K7 | 0.64066266 |
| 84 | RIPK1 | 0.62684792 |
| 85 | CAMK1G | 0.62516144 |
| 86 | FLT3 | 0.60516043 |
| 87 | IRAK2 | 0.60486559 |
| 88 | PIK3CG | 0.59888723 |
| 89 | CAMKK1 | 0.58645964 |
| 90 | PDK1 | 0.58472979 |
| 91 | MAP3K8 | 0.56629395 |
| 92 | PRKD2 | 0.55814595 |
| 93 | DMPK | 0.54432347 |
| 94 | TESK2 | 0.54079827 |
| 95 | PDGFRB | 0.52428562 |
| 96 | MAP2K2 | 0.48629358 |
| 97 | FGR | 0.46658400 |
| 98 | TAOK1 | 0.42687787 |
| 99 | RPS6KA6 | 0.42083198 |
| 100 | MAPK4 | 0.41426052 |
| 101 | MARK2 | 0.40903071 |
| 102 | HIPK2 | 0.39857237 |
| 103 | MAP3K6 | 0.39661823 |
| 104 | MAP3K5 | 0.39081965 |
| 105 | MAPKAPK2 | 0.38753363 |
| 106 | MAPK7 | 0.38526976 |
| 107 | MOS | 0.38272726 |
| 108 | SIK1 | 0.38205248 |
| 109 | STK24 | 0.38102326 |
| 110 | EPHA3 | 0.37979565 |
| 111 | CDK19 | 0.37170090 |
| 112 | DYRK1B | 0.36944358 |
| 113 | RET | 0.36825464 |
| 114 | ABL1 | 0.36768165 |
| 115 | RPS6KB2 | 0.36767640 |
| 116 | STK38 | 0.35676816 |
| 117 | MAPK12 | 0.35354331 |
| 118 | NME2 | 0.35339791 |
| 119 | EGFR | 0.35301883 |
| 120 | MAPK11 | 0.34375972 |
| 121 | INSR | 0.34192693 |
| 122 | FYN | 0.33223404 |
| 123 | * MARK3 | 0.33145293 |
| 124 | MAP2K6 | 0.32829381 |
| 125 | RPS6KL1 | 0.32075695 |
| 126 | RPS6KC1 | 0.32075695 |
| 127 | STK3 | 0.31299809 |
| 128 | SGK3 | 0.28309964 |
| 129 | PAK4 | 0.25955939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.01489087 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.74673092 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.62306519 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55004138 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46527181 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45552703 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45024923 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.32864849 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.28425802 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22038869 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16451536 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11418201 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90283656 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80558728 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73138683 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62903705 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.62454052 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59483793 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58996022 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58176257 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54019937 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51848320 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48336249 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48213617 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46702692 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44792913 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.44487970 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.39491532 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38868212 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38447005 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.36798971 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.36362151 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.34132463 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.32959516 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26339974 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24231944 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.23717051 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.22780565 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.22156303 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.22056354 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.16504723 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14925180 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13025157 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.12468548 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11644333 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05069082 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04468653 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02103941 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98672200 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.97681763 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97547996 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94801963 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93708766 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93036048 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92824958 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88255660 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87785905 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.87544854 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87481844 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86528719 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80603895 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78928295 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77536382 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76490594 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76107278 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.73614901 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72716627 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72149932 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71881095 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70388769 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70169938 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64197964 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63212101 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61376844 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.61223479 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60139144 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.60087152 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57517873 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57496084 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57483848 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.55804783 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54489187 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54269074 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54129939 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53809788 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.52944413 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52941333 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52780800 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.52379544 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51720991 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50526740 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48175866 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47860852 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46370056 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46074542 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45617510 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.44808724 |
| 98 | Base excision repair_Homo sapiens_hsa03410 | 0.44188628 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43927733 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42967674 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42729288 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42480741 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41873568 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41569055 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41004141 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40939964 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40076789 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.39408983 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.38532462 |
| 110 | Cell cycle_Homo sapiens_hsa04110 | 0.38114231 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37923370 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35472790 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.35216224 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.33898539 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.31995399 |

